Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sunita Misra, MD
SK Life Science, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Children'S Hospital Melbourne
Parkville, Australia
- Sydney Children'S Hospital - Randwick
Randwick, Australia
- Children'S Health Queensland Hospital and Health Service
South Brisbane, Australia
- Charite University Hospital
Berlin, Germany
- Bethesda Gyermekkorhaz
Budapest, Hungary
- Országos Klinikai Idegtudományi Intézet, Neurológiai Osztály
Budapest, Hungary
- Semmelweis University Dept. of Paediatrics
Budapest, Hungary
- Servus Salvus Egészségügyi Szolgáltató Kft.
Budapest, Hungary
- Niepubliczny Zaklad Opieki Zdrowotnej - Centrum Neurologii Dzieciecej I Leczenia Padaczki
Kielce, Poland
- Centrum Medyczne Plejady
Krakow, Poland
- Wojewódzki Specjalistyczny Szpital Dziecięcy Im. Św. Ludwika W Krakowie
Krakow, Poland
- Chungbuk National University Hospital
Cheonju, South Korea
- Korea University Guro Hospital
Seoul, South Korea
- Smg-Snu Boramae Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- Ajou University Hospital
Suwon, South Korea
- Hospital Sant Joan de Déu Barcelona
Barcelona, Spain
- Hospital Universitari Vall D'Hebrón
Barcelona, Spain
- Hospital Infantil Universitario Niño Jesús
Madrid, Spain
- Hospital Universitario Virgen del Rocío
Seville, Spain
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Lucile Packard Children'S Hospital Stanford
Palo Alto, California, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Clinical Integrative Research Center of Atlanta
Sandy Springs, Georgia, United States
- Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Northeast Regional Epilepsy Group
Hackensack, New Jersey, United States
- Northeast Regional Epilepsy Group - Morristown
Morristown, New Jersey, United States
- Boston Children'S Health Physicians - Neurology at Hawthorne
Hawthorne, New York, United States
- Duke University Hospital
Durham, North Carolina, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Main Campus
Cleveland, Ohio, United States
- Le Bonheur Children'S Hospital
Memphis, Tennessee, United States
- Child Neurology Consultants of Austin
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jan 2022
- Primary completion
- 30 Nov 2026
- Completion
- 30 Nov 2026
- Last update posted
- 13 Aug 2026
- Registered enrollment
- 140
- Registry id
- NCT05067634
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.